Nerliens Meszansky AS appoints Nina Nielsen Bjerke as new CEO

Nerliens Meszansky AS welcomes Nina Nielsen Bjerke as the new Chief Executive Officer from May 1st, 2023. Nina is promoted from her role as Sales Director and brings more than 20 years of experience from the LifeScience and LabSupplies industry. Nina is replacing CEO Asbjørn Jacobsen, who will go into retirement. "It is an exciting challenge to receive the board`s trust as the new CEO of Nerliens Meszansky. I look forward contributing to our future success together with our talented and dedicated employees," says Nina Nielsen Bjerke. Nerliens Meszansky AS has grown significantly in recent years and strengthened its leading position in the industry.

Asbjørn Jacobsen will continue to contribute as a Board Member of Nerliens Meszansky AS, as well as Board Member of the subsidiary Nordic Biolabs AB.

Chairman of the Board, Christian Petersen, expresses on behalf of the board his gratitude to Asbjørn Jacobsen, saying that "it has undoubtedly been very rewarding to work with Asbjørn, and Asbjørn has been a significant contributor to the company’s success over many years. At the same time, we warmly welcome Nina Nielsen Bjerke in her new role, and I look very much forward to a rewarding and long collaboration with her".

Press contact:
Nina Nielsen Bjerke, +47 908 23 678, nina.nielsen.bjerke@nmas.no
Christian Petersen, +47 982 55 052, christian@vindgroup.com